Today’s AI Top Pick: COO

9/14/2026 · Contrarian screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

The desk streams live daily· see the schedule →

Today's pick · ContrarianCOOBUY NOW8.6 / 109/14/2026

Cooper Companies (COO) is the cleanest 'exhausted seller' setup in this pool. RSI is at 14.52 — a genuinely capitulatory reading for a $10.25B large-cap healthcare name, not a micro-cap. The 1d position_in_21bar_range is 1.62% and 4h is 0%, so we are buying near the low of the range, not chasing a bounce that has already started. Crucially, every single timeframe forecast agrees: 4h fc_short +42.98% / fc_mid +42.27% / fc_long +45.61%, 1d fc_short +20.55% / fc_mid +35.03% / fc_long +29.94%, and 1wk fc_short +25.68% / fc_mid +44.37% / fc_long +57.96%. Bullish probability is 1.0 with near_term_bullish 1.0 — that is textbook multi-timeframe alignment. Fundamentals separate COO from the biotech/microcap forecast-lottery names on this list. PE 18.4, fwdPe 11.46, PEG 1.55, profitMargin 13.46%, operMargin 19.26%, ROE 6.84%, salesYoY +4.73%, debtEq 0.31, instOwn 112.7% — this is a durable business, not a going-concern story. Analyst recom 2.37 with targetUpsidePct +22.1% is supportive without being frothy. Fundamental_score of 4.5 is second-best among the large caps here and materially better than the small-cap forecast-heavy tickers. The news check passes: Mizuho maintained Outperform (only trimmed PT to $75), and the recent earnings coverage frames this as inventory/strategic-review noise rather than a broken thesis. Contrast that with TTAN (headline literally says 'crashes 30% as AI creates a surprising problem' — a structural threat, not a dip), RWT (just priced $185M in dilutive convertible notes), and GWRE (CEO insider selling + weekly forecast is actually NEGATIVE at -8% to -15%). Those are the reasons a higher raw 'score' doesn't win. Today is the right entry because we have (a) capitulation RSI, (b) price pinned at the bottom of the 21-bar range on both intraday and daily, (c) all four forecast horizons pointing up double-digits, and (d) no fresh landmine in the tape. Waiting means missing the base — the 4h forecast is already calling +43% short-term, so a pullback entry may not come.

Entry zone

$53.80–$54.80 (scale in at current $54.28; add on any dip to $53.50 which is near the 21-bar low)

Stop loss

$49.90 (below the recent capitulation low, ~8% risk — if it breaks, the bounce thesis is invalid)

First target

$62 (roughly +14%, aligns with 1d fc_short +20% partial and fills the initial rejection zone)

Longer target

$74–$77 (aligns with 1wk fc_long +57% context and Mizuho's $75 PT; ~40% upside over the swing horizon)

Risks

CooperVision segment weakness flagged in Q2 coverage — if myopia/contact lens demand doesn't stabilize, forecasts will re-rate lower
Mizuho already lowered PT to $75 (from higher); further sell-side cuts could re-trigger selling despite RSI 14.52
Stock is down -34.22% YTD and -21.25% over the year — trend is broken on the weekly, so this is a mean-reversion trade not a trend trade
PEG of 1.55 and salesYoY of just 4.73% means growth is not accelerating; multiple expansion needs sentiment to shift
Healthcare sector rotation risk — if capital keeps flowing to AI/crypto (see BTC at $78k while AI selloff continues), defensive medtech may lag the broader bounce

Honorable mentions

ENOVInsider purchase (Oliver Engert bought 2,660 shares) is a real positive catalyst, all-timeframe forecast agreement (4h +40%, 1d +26–53%, 1wk +30–131%), position at 0–8% of range, fwdPe 5.22 and PEG 0.75 are cheap. Slightly lower conviction than COO due to -47.9% profitMargin and shortFloat 16.17%.

NNVCEvery timeframe bullish (1d fc_mid +47%, 1wk fc_long +48%), RSI 20.09, position at 0% of range, and a real catalyst with the Ebola Phase II trial registration in DR Congo. Micro-cap ($26M) risk keeps it out of the top spot but it's the best pure-narrative bounce.

Full ranking (16)

#	Symbol	Verdict	Score	Read
1	COO	BUY NOW	8.6	Large-cap oversold (RSI 14.52) with all four timeframes forecasting +20% to +58% and clean fundamentals — cleanest exhausted-seller setup.
2	ENOV	BUY NOW	8.0	All-TF alignment (+30% to +131% on weekly), insider buying, cheap fwdPe 5.22, position near range low.
3	NNVC	BUY NOW	7.4	Micro-cap with genuine Ebola trial catalyst, RSI 20.09, every horizon bullish — size the position small.
4	ADSK	BUY PULLBACK	7.0	Best fundamentals in pool (score 8, ROE 53.85%), but 4h position_in_range is 100% — wait for a pullback to $205 area.
5	CXM	BUY PULLBACK	6.4	1wk fc_long +83.76% is compelling but 4h is at 100% of range and revenue grew only 1% — wait for a dip to $5.10.
6	KVYO	BUY PULLBACK	6.1	4h at 75% of range and 1wk fc_short only +15% — mixed signal, wait for retest of $15.50.
7	NMRA	BUY NOW	6.0	1d fc +96–103% and position 0–6.6% of range, but -187% ROE — pure speculation size only.
8	LUCD	WAIT	5.6	1wk fc_mid is -15% despite short-term positive — weekly rollover risk undercuts the bounce.
9	SDA	WAIT	5.4	Forecasts (+338% weekly) are numerically absurd for a $56M cap with 0.29% instOwn — don't trust.
10	RDZN	WAIT	5.2	1wk fc_short and fc_mid both NEGATIVE (-18%, -14%) — near-term forecast contradicts thesis.
11	TTAN	AVOID	5.0	Highest raw score but headline literally says 'AI creates a surprising problem' — structural threat, not just a dip.
12	IVVD	WAIT	4.8	Forecasts strong but -183.9% profitMargin and -68% YTD — too broken for a bounce trade.
13	RWT	AVOID	4.5	Just priced $185M dilutive convertible notes — kills the bounce thesis regardless of RSI 17.41.
14	GWRE	WAIT	4.3	1wk forecast is NEGATIVE (-8% to -15%) and CEO sold shares — multi-TF alignment fails.
15	AEMD	AVOID	4.0	1wk fc of +12,415% is noise on a $2.45M cap — untradeable.
16	RPD	AVOID	3.8	near_term_bullish 0.0, 1d fc only +3.27%, recom 3.19 — no edge here.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord